Vachellia farnesiana
Vachellia farnesiana · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Vachellia farnesiana is a versatile plant species that has gained significant scientific interest due to its diverse array of bioactive compounds. Research into its various preparations, including pod polyphenol extracts, active fractions, and dichloromethane fractions, has revealed a rich chemical profile. These extracts are characterized by the presence of key substances such as chitinase, hydroxycinnamic acids, methyl gallate, and catechins. The plant demonstrates promising pharmacological potential through its roles as a 11B-HSD inhibitor, a 5-alpha-reductase inhibitor, a 5-HT inhibitor, and a 5-lipoxygenase inhibitor. Consequently, these biological activities suggest its therapeutic relevance in addressing medical conditions such as dysentery and tuberculosis.
- Synonyms
- Acacia Farnesiana · Poponax Farnesiana · 1 more
- Common names
- Not available
- Family
- Fabaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Vachellia farnesiana is a versatile plant recognized by a diverse array of regional and common names across the globe. In certain areas, it is affectionately known as Acácia-de-dioscórides or as the Amber Ağacı. Its linguistic reach extends further through names such as Antilinė akacija and Antillenakazie. Additionally, the species is frequently referred to as Arapiraca in specific botanical contexts. These varying identifiers highlight the widespread presence and cultural significance of this unique species.
Sources: Catalogue of Life (COL)
Synonyms
Vachellia farnesiana is a botanical subject frequently identified by several different taxonomic names. Depending on the scientific literature being consulted, it is often referred to by the synonym Acacia farnesiana. Researchers may also encounter the plant documented under the name Mimosa farnesiana in various botanical records. Furthermore, the designation Poponax farnesiana serves as another recognized synonym for this specific species. Understanding these various nomenclatural relationships is essential for accurate identification in the field.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Vachellia farnesiana is a distinctive species that belongs to the kingdom Plantae. Within this vast biological kingdom, it is classified under the class Equisetopsida. The plant is further organized into the order Fabales, showcasing its specific evolutionary lineage. It is a member of the Fabaceae family, a group known for many ecologically significant plants. Ultimately, this species is defined by its placement within the genus Vachellia.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Fabales |
| Family | Fabaceae |
| Genus | Vachellia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Vachellia farnesiana exhibits a diverse geographical distribution that spans several key regions across the African continent. Within East Tropical Africa, this species can be found thriving in the landscapes of both Tanzania and Uganda. Its presence also extends northward to the Macaronesia islands, establishing roots in unique Atlantic environments. Specifically, the plant is well-documented across the Canary Islands, Cape Verde, and Madeira. This wide-ranging habitat highlights the remarkable adaptability of the species to various African climates.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Vachellia farnesiana is a self-supporting plant that takes on a distinct tree growth form. Depending on its environment, this species can vary significantly in scale, with heights ranging from as little as 1 meter to a maximum of 30 meters. While it can remain relatively small, it frequently reaches more substantial dimensions, often exceeding 9.53 meters in height. This versatility in stature allows the plant to adapt to various ecological niches. Ultimately, its structural integrity as a tree makes it a prominent feature in its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Vachellia farnesiana pods are notably rich in a diverse array of bioactive polyphenols. These specific compounds include beneficial elements such as quercetin and catechins. Additionally, the plant contains methyl gallate and various hydroxycinnamic acids. Research into these constituents aims to explore their potential role in metabolic regulation and glucose homeostasis. Current clinical evidence suggests that these polyphenol-rich extracts are safe for human consumption.
Conditions
Vachellia farnesiana demonstrates significant therapeutic potential by inhibiting the adherence of Campylobacter to Vero cells. The plant's extracts also effectively treat the cytotoxic activity of bacterial cultures, specifically targeting microorganisms like Campylobacter jejuni and C. coli. Furthermore, its antidysentery properties are supported by its ability to combat various dysentery-causing bacteria. In terms of metabolic health, the plant shows promise in managing glucose homeostasis through its polyphenol-rich pod extracts. These components further contribute to glycemic regulation, offering a potential natural approach to maintaining healthy blood sugar levels.
Preparations
Vachellia farnesiana is prepared as a pod polyphenol extract to evaluate its safety and potential effects on glycemic regulation and incretin hormones in humans. This medicinal plant is also prepared as various extracts, including water and ethanolic versions, to study their anti-hyperglycemic and antimicrobial properties. From these preparations, an active fraction (AF) can be isolated through alcohol precipitation to investigate specific mechanisms of action like glucose uptake. Further specialized isolation involves processing the plant into n-hexane and dichloromethane (DCM) fractions for the study of secondary metabolites. These specific fractions, such as the n-hexane fraction and the DCM fraction, have demonstrated significant biological activities including high cytotoxicity and glucose-lowering capabilities.